What question did this study set out to answer?

To review the epidemiology, pathophysiology, and clinical management dilemmas surrounding atrial fibrillation in patients with end-stage renal disease.

October 29, 2007Pacing and Clinical Electrophysiology

Atrial Fibrillation in End‐Stage Renal Disease

View Full Paper

Ask AI

Bookmark

Population

Patients with end-stage renal disease (ESRD) and atrial fibrillation (AF)

Design

Review

Authors

PKPanagiotis KorantzopoulosElectrophysiology SKStelios KokkorisNational and Kapodistrian University of Athens TLTong LiuElectrophysiology

Discussion

Member takes

Implication

Anticoagulation remains underused in ESRD-AF due to bleeding concerns; leaves open optimal net-benefit thresholds for prospective trials.

Key Points

To review the epidemiology, pathophysiology, and clinical management dilemmas surrounding atrial fibrillation in patients with end-stage renal disease.
Synthesized existing literature on the pathophysiology and cardiovascular outcomes of atrial fibrillation in end-stage renal disease.
Evaluated the clinical challenges associated with anticoagulation therapy and hemorrhagic risk in this population.
Atrial fibrillation is highly prevalent among patients with end-stage renal disease and significantly increases cardiovascular morbidity and mortality.
Anticoagulation therapy is frequently withheld from these patients due to substantial risks of serious hemorrhagic complications.

Structured PICO

Population

Patients with end-stage renal disease (ESRD) and atrial fibrillation (AF)

This review highlights the clinical challenges of managing atrial fibrillation in patients with end-stage renal disease, particularly the underuse of anticoagulation due to bleeding risks.

Cite This Study

Korantzopoulos et al. (2007) studied this question.

synapsesocial.com/papers/6a849211cdf3a848bdbd952b https://doi.org/10.1111/j.1540-8159.2007.00877.x

Topics

Atrial fibrillation Persistent AF management Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Atrial Fibrillation in End‐Stage Renal Disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Atrial Fibrillation in End‐Stage Renal Disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider